In glutaric aciduria type 1, glutaryl-coenzyme A and its derivatives are produced from intracerebral lysine and entrapped at high concentrations within the brain, where they interfere with energy metabolism. Biochemical toxicity is thought to trigger strokelike striatal degeneration in susceptible children under 2 years of age. Here, we explore vascular derangements that might also contribute to brain damage. We studied injured and non-injured Amish glutaric aciduria type 1 patients using magnetic resonance imaging (n = 26), transcranial Doppler ultrasound (n = 35) and perfusion computed tomography (n = 6). All glutaric aciduria type 1 patients had wide middle cerebral, internal carotid and basilar arteries. In non-injured patients, middle cerebral artery velocities were 18-26% below control values throughout late infancy and early childhood, whereas brain-injured children had an early velocity peak (18 months) and low values thereafter. Perfusion scans from six patients showed that tissue blood flow did not undergo a normal developmental surge. We observed four different perfusion patterns. (i) Three children (two noninjured) had low cerebral blood flow, prolonged mean transit time, elevated cerebral blood volume and high mean transit time/ cerebral blood flow and cerebral blood volume/cerebral blood flow ratios. This pattern optimizes substrate extraction at any given flow rate but indicates low perfusion pressure and limited autoregulatory reserve. (ii) Ten hours after the onset of striatal necrosis in an 8-month-old infant, mean transit time and cerebral blood volume were low relative to cerebral blood flow, which varied markedly from region to region. This pattern indicates disturbed autoregulation, regional perfusion pressure gradients, or redistribution of flow from functional capillaries to non-exchanging vessels. (iii) In an infant with atrophic putaminal lesions, striatal flow was normal but mean transit time and cerebral blood volume were low, consistent with perfusion in excess of metabolic demand. (iv) Finally, a brain-injured adult with glutaric aciduria type 1 had regional perfusion values within the normal range, but the putamina, which normally have the highest regional perfusion, had cerebral blood flow values 24% below cortical grey matter. Although metabolic toxicity appears central to the pathophysiology of striatal necrosis, cerebrovascular changes probably also contribute to the process. These changes may be the primary cause of expanded cerebrospinal fluid volume in newborns, intracranial and retinal haemorrhages in infants and interstitial white matter oedema in children and adults. This pilot study suggests important new areas for clinical investigation.
Introduction
Glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type 1, GA1) is an autosomal recessive disorder of mitochondrial lysine and tryptophan degradation. It is prevalent among Old Order Amish of Lancaster County (Morton et al., 1991) due to a 1262C4T (A421V) mutation in the gene coding for glutaryl-CoA dehydrogenase (GCDH). Glutaryl-CoA is proximal to the enzyme block and its derivatives (glutarate, 3-hydroxyglutarate and glutarylcarnitine) accumulate in tissues, particularly the brain (Goodman et al., 1977; Bennett et al., 1986; Kolker et al., 2003; Funk et al., 2005) .
Despite early diagnosis, one-third of affected Amish infants develop striatal lesions within medial and lateral lenticulostriate distributions of the middle cerebral artery (MCA) (Feekes and Cassell, 2006; Strauss et al., 2007) . Brain injury is often sudden, like a stroke. Even in cases of insidious motor delay, lesions may occur suddenly during antenatal or neonatal life only to become evident between 2 and 6 months of age (Strauss et al., 2007) .
The term 'metabolic stroke' has been applied to GA1 and other disorders in which a primary derangement of the tricarboxylic acid cycle or respiratory chain, rather than ischaemia, is thought to trigger neuronal necrosis (Hoffmann et al., 1994; Haas et al., 1995; Oppenheim et al., 2000; Abe et al., 2004; Strauss et al., 2007) . There is experimental evidence that some form of energy failure is central to the pathophysiology of GA1 (Kolker et al., 2004; Sauer et al., 2005; Strauss et al., 2007; Zinnanti et al., 2007) . However, the only direct evidence of an energy disturbance in humans comes from fluorodeoxyglucose positron emission tomography studies of asymptomatic Amish infants showing glucose tracer uptakes reduced by 28, 27, 18 and 14% in putamen, caudate, thalamus and cortical grey matter, respectively (Strauss et al., 2007) .
Although these studies support the metabolic hypothesis of GA1, the physiology may be more complex. We have long recognized that expansion of cerebrospinal fluid (CSF) volume and intradural haemorrhages in affected infants might result from haemodynamic rather than metabolic mechanisms (Mandel et al., 1991; MartinezLage, 1996; Muhlhausen et al., 2004; Hernandez-Palazon et al., 2006; Strauss et al., 2007) , and a limited number of perfusion computed tomography (CT) scans suggest that cerebral blood volume (CBV) and mean transit time are elevated in some children. Based on these and other observations, we hypothesized that metabolic inhibition of brain tissue entrains haemodynamic changes (Strauss et al., 2007) .
Here, we explore how such changes might relate to brain metabolism, intracranial fluid dynamics, haemorrhage risk and striatal damage. Our study of the MCA was guided by a simple idea: if flow-metabolism coupling remains intact, a 14%-28% decrease of cerebral metabolism should be matched by similar decreases of blood velocity (Wahl and Schilling, 1993; Hudetz, 1997a) . Based on Doppler results, we reanalysed perfusion scans (Strauss et al., 2007) to understand the correlation between MCA flow and capillary perfusion. Our results suggest that cerebral toxicity caused by GCDH deficiency may induce a state of arteriolar dilation and increased CBV. This implicates cerebral venous hypertension as a mechanism of CSF expansion, intradural haemorrhage and interstitial oedema, suggesting that perfusion pressure, like glucose delivery, might be an important treatment variable.
Patients and methods

Estimation of cerebral vessel cross-sectional area
The ethics review board of Lancaster General Hospital approved the study and parents consented to participation. We studied MRI scans of 26 patients with GA1 and 26 age-matched control subjects between birth and 30 months of age. Images were obtained with a Siemens 1.5T Symphony scanner (Siemens Medical Systems). DicomWorks imaging software (http://dicom.online.fr/) was used to measure the diameter of the middle cerebral, internal carotid and basilar arteries. To minimize error, vessels were measured end-on (sagittal view of the middle cerebral arteries, coronal view of the internal carotids within the cavernous sinous and axial view of the basilar artery; see Fig. 2 , upper panels). Vessel cross-sectional area was calculated: cross-sectional area (in mm
, where p equals 3.14 and d is vessel diameter in millimetres (i.e. 0.5d equals vessel radius).
The cross-sectional area of each MCA was determined relative to the combined cross-sectional areas of the major cerebral feeding vessels:
where MCA f is fractional MCA cross-sectional area relative to the sum of cross-sectional areas for the left internal carotid (ICA l ), right internal carotid (ICA r ) and basilar (BA) arteries. Values for relative crosssectional area were log transformed to produce a normal distribution for statistical analyses.
Measurement of middle cerebral artery velocity
We performed transcranial colour Doppler ultrasound of the proximal MCA segment in 35 GA1 children ages 1 week to 14 years. Twentysix children were Amish and homozygous for the GCDH 1262C4T mutation. Those remaining were compound heterozygous for various mutations in GCDH. Several children with GA1 were imaged at serial time points (e.g. Fig. 9 , lower row), yielding a total of 95 transcranial colour Doppler studies. Children with GA1 were grouped according to neurological disability: children who had dystonia and MRI-documented striatal lesions were designated 'injured' (n = 18) and those who had normal motor development and function were designated 'non-injured' (n = 17). All but one of the injured children had atrophic striatal lesions before being imaged (Strauss et al., 2007) . For one child (Case 2 below), acute striatal necrosis occurred during the course of the study and transcranial colour Doppler measurements were available before and after the event (Fig. 8, column C) .
Control transcranial colour Doppler data were collected from 86 healthy age-matched Mennonite and Amish children, two-thirds of whom were siblings of GA1 patients. To account for normal developmental changes in cerebral blood velocity, we assigned transcranial colour Doppler measurements to six different age groups (0-3 months, 4-6 months, 7-12 months, 13-24 months, 2-6 years and 7-14 years) (Supplementary Table 1 ) (Wintermark et al., 2004) . In Figs 4, 5, 7 and 9, age is depicted on a log 2 scale for graphical clarity.
All Doppler images were obtained by a single technician using an High Density Imaging 5000 ultrasound system (Philips Medical Company) equipped with a low frequency phased array transducer (P4-2) operated at 2 MHz in pulse wave mode. We assumed an insonation angle (ø) of 0 . Angle correction was not used; the true ø was estimated to be between 0 and 25 , yielding a maximum error of 9% (i.e. 1 -cos25).
With the child supine, the transducer was oriented in the transverse plane over the thinnest portion of the temporal bone, cephalad to the zygomatic arch, to identify the circle of Willis and locate the proximal segment of the MCA. We measured peak systolic velocity (V sys ), end-diastolic velocity (V dia ), and time-averaged mean flow velocity (V mean ) in cm/s. These values were used to calculate pulsatility index (PI):
Perfusion computed tomography
Perfusion data were obtained using a published protocol and analysed with PCT software (Wintermark et al., 2001 (Wintermark et al., , 2004 . CBV (ml/100 g) was divided by mean blood transit time (seconds) to calculate cerebral blood flow (CBF; in ml/100 g per minute) for nine grey matter regions (caudate, putamen, thalamus, frontal cortex, central and calcarine sulci and frontal, parietal, temporal and occipital cortices) and four subcortical white matter regions (frontal, parietal, occipital, temporal). The inverse mean transit time (in s
À1
) was also used to construct Fig. 6 because it is intuitively similar to velocity and has a linear relation to CBF (r s = 0.82, P50.0001).
Perfusion CT scanning was done on six GA1 patients: two noninjured (aged 12 and 20 months), three with atrophic striatal lesions (ages 5.5 months, 20 months and 25 years) and one 8-month-old child in acute cerebral crisis, 10 and 100 h after the onset of opisthotonus (Case 2) (Strauss et al., 2007) . Values from GA1 patients were compared with previously published control data from 53 children, ages 7 days to 18 years (28 male and 25 female) (Wintermark et al., 2004) . To account for perfusion changes during development, the control group was divided into four paediatric subsets matched closely for age to individual GA1 patients (Supplementary Table 2 ).
Data analyses
Statistical analyses were performed using Prism4 software (http:// www.graphpad.com). Vessel cross-sectional area as a function of age was studied with least-squares linear regression according to the equation y = Mx + b, where y is calculated vessel cross-sectional area in mm 2 , M is the regression coefficient (slope), x is age in months and b is the estimated cross-sectional area at birth (i.e. when x = 0). The value r 2 signifies the strength of association between age and vessel cross-sectional area. Left and right velocity and cross-sectional area measurements obtained from each patient were counted independently; i.e. the number of measurements was twice the number of subjects (Table 1) . MCA velocity measurements were normally distributed within each of the six age designations listed in Supplementary 
Normal z scores are between À2 and +2.
Results
Two cases are summarized below to illustrate the characteristic disturbance of CSF volume and brain water in infants with GA1 (Case 1), as well as perfusion abnormalities recorded during an acute striatal injury (Case 2). These and other cases prompted the haemodynamic studies that follow:
Case 1: Increased cerebrospinal fluid volume and interstitial brain oedema An infant with GA1 was born with a large head (head circumference 40 cm; z = +4.6), widely split cranial sutures, prominent Case 2: Acute striatal degeneration, low regional cerebral blood volume and signs of ischaemia
In a previous publication (Strauss et al., 2007) , we detailed the evolution of striatal injury in an Amish boy with GA1; his story is briefly summarized here. He was diagnosed with GA1 on his first day of life and treated with L-carnitine (80 mg/kg/day) and a lysine-restricted diet (lysine 71 AE 9 mg/kg/day, tryptophan 24 AE 4 mg/kg/day and lysine-free L-amino acids 0.5 g/kg/day). Head growth was stable along the 95th percentile. At age 6 months he had mild axial hypotonia and chorea of the distal upper limbs. At age 7 months he could not sit independently but could control his head and use his hands. At age 8 months, he developed sudden opisthotonus. A perfusion scan 10 h later showed low mean grey matter blood flow (z = À0.5), blood volume (z = À1.1) and transit time (z = À0.5), with markedly variable perfusion from region to region ( Fig. 2 ; see Table 1 for age-matched control values used to calculate z scores). For example, flow to the right putamen was only half that of adjacent caudate, but both values were still within a broad age-matched normal range (z = À0.7 and +0.3, respectively). MRI and CT scans 90 h later showed cytotoxic oedema (apparent water diffusion 0.64 Â 10 À3 mm 2 /s; z = À4.2) and reduced perfusion (z = À1.2) of striatal nuclei. Opening pressure of the thecal sac was 14 cm H 2 O (normal 19.0 AE 4.4 cm H 2 O). CSF neuron-specific enolase, a marker for neuronal lysis, was elevated (21.8 ng/ml; normal 3.5 AE 1.4 ng/ml). There was no biochemical evidence of encephalitis or blood-brain barrier dysfunction and spinal fluid glucose, lactate, amino acids and neurotransmitter metabolites were normal. Organic acid concentrations of CSF (glutarate 6.6 mmol/l, 3-hydroxyglutarate 0.45 mmol/l) were similar to those of plasma (glutarate 10.1 mmol/l, 3-hydroxyglutarate 0.53 mmol/l). The child made no motor progress over ensuing months. He had crippling dystonia by 1 year of age, when a repeat brain MRI showed severe striatal atrophy.
Figure 2 An 8-month-old Amish boy with GA1, compliant with diet and carnitine therapy, presented with acute opisthotonus. There was no precipitating illness. Perfusion parameters measured in multiple regions (left panel) at 10 h (red bars) and 100 h (blue bars) after the onset of dystonic posturing were compared with control regional mean values (grey bars; n = 5). Selected regions are ordered on the X-axis as they appear left to right across an axial section of the brain; dotted lines represent mean minus one standard deviation for nine grey matter regions measured in five control children age 8 AE 3 months (n = 45 total measurements). At 10 h, mean transit time (MTT) and CBV are relatively low and regional CBF is markedly heterogenous. However, flows to the putaminae and caudates are within the normal range. At 100 h, CBVs are stable or diminished whereas mean transit times have increased, leading to frank ischaemia in deep grey matter structures, including putaminae. Cd = caudate nucleus; Ctx = frontal and parietal corticies; Put = putamen; Th = thalamus.
Vessel calibre
In children from all groups (control, GA1 injured and GA1 noninjured), cerebral feeding vessels, as depicted in Fig. 3 , grew wider over the first 30 months of age (r 2 for MCA = 0.39 in control and 0.66 in GA1 subjects). Compared with control subjects, GA1 patients between 6 and 20 months of age had 34%-42% larger MCA (P50.0001) and 20%-49% larger combined vessel (P50.0001) cross-sectional area. Proportional cross-sectional area of the MCA [i.e. MCA/(ICA l + ICA r + BA)] was similar among groups, although there were outliers among injured patients (Fig. 3B ).
Middle cerebral artery velocity
In control subjects, MCA velocity increased by 80% over the first few years of life and declined after age 6 (Fig. 4) . In non-injured GA1 patients, velocity did not surge but instead increased slowly to reach normal levels by age 6. The difference was greatest between 13 and 24 months of age, when mean velocity in GA1 children was 26% less than in controls (P50.0001). In brain-injured patients, MCA velocity peaked at $18 months of age and was low thereafter. Velocity measurements overlapped among injured and non-injured GA1 children and varied considerably over time in each individual (Fig. 9 , lower row). Thus, MCA velocity could not be reliably used to determine the risk for or presence of brain injury. Pulsatility indices from both non-injured and injured GA1 children were similar to control values but differed significantly from each other during the second year of life (Fig. 5) .
Regional grey matter perfusion
Perfusion data in Fig. 6 depict relationships of CBF to mean transit time, inverse mean transit time and CBV for nine grey matter and Figure 3 Upper panels show MRI slices used to measure cerebral vessels end-on (white arrows). From left to right: sagittal view of proximal MCA, coronal view of internal carotid arteries within the cavernous sinus and axial view of the basilar artery at the level of the pons and middle cerebellar peduncles. (A) MCA cross-sectional area (mm 2 ) as a function of age for control subjects (grey squares), healthy GA1 children (white circles) and brain-injured GA1 children (white triangles). MCA cross-sectional area was larger in children with GA1 regardless of injury status. A similar pattern was found for the internal carotid and basilar arteries (data not shown). (B) MCA cross-sectional area relative to the sum of internal carotid [left (ICl) and right (ICr)] and basilar (BA) crosssectional areas did not differ among groups. However, this measurement was quite variable among brain-injured children.
four white matter regions among 53 control subjects ages 7 days to 18 years (Wintermark et al., 2004) . Blood flow correlated inversely with mean transit time (r s = À0.82, P50.0001) and had a linear relationship to inverse mean transit time (r 2 = 0.65, P50.0001) suggesting that velocity is a strong determinant of flow. Blood flow correlated only weakly with CBV (r s = 0.27, P50.0001) and there was no correlation between CBV and mean transit time. Consistent with Doppler data, CBF did not surge in children with GA1 (Fig. 7) . Among six patients, we observed four different perfusion patterns (summarized in Table 1 and Figs 8-10):
(i) High volume, slow velocity (n = 3): A 12-month-old noninjured child had reduced CBF and elevated CBV. Mildly increased mean transit time was not statistically different from control (Table 1) . Two 20-month-old girls, one injured and one non-injured, had low CBF, high CBV and high mean transit time in all grey matter regions; CBF varied considerably from region to region (Fig. 9A) . mean AE 1 SD), reflecting a progressive rise in perfusion pressure. MCA pulsatility for both non-injured (white circles) and injured (white triangles) GA1 patients was not statistically different from controls subjects. However, visual inspection reveals a less pronounced slope of the pulsatility index curve in non-injured patients. (B) In brain-injured children, pulsatility index decreased markedly during the second year of life, possibly indicating a transient change of perfusion pressure or cerebrovascular resistance. Age in months is plotted on a log 2 scale (
(ii) Acute striatal injury-low volume, high velocity, heterogenous perfusion (n = 1): An 8-month-old boy was imaged 10 and 100 h after the onset of an acute striatal injury (Case 2). At 10 h, mean transit time and CBV values were low (Table 1 , Fig. 9B ). Regional CBF values, although markedly heterogenous, were within a broad age-appropriate range (Table 1) . By 100 h into cerebral crisis, mean transit time normalized, CBV remained low and the striata and thalami were ischaemic (Fig. 2) . Only the striata, however, subsequently degenerated. (iii) Chronic atrophic lesions-low volume, high velocity, homogenous perfusion (n = 1): Regional CBFs were normal but both mean transit time and CBV values were low in a 5.5-monthold girl with chronic atrophic striatal lesions (Fig. 9C ). (iv) Low putaminal blood flow (n = 1): A 25-year-old injured patient had tightly clustered CBF, CBV and mean transit time values within the adult normal range (Table 1) . However, CBF in gliotic putamen was 24% below values in cortex.
These patterns are more clearly differentiated in Fig. 10 , which shows mean transit time versus CBV for three individuals. 
Figure 7
Grey squares show age-specific mean AE SD perfusion CT blood flow measurements (in ml/100g-min) from nine grey matter regions among 53 control subjects aged 7 days to 18 years (data redrawn from Wintermark et al., 2004) . The developmental surge in perfusion was not observed in GA1 patients (white circles). Age in months is on a log 2 scale.
Cerebral haemodynamics in GA1 In healthy children, cerebral growth, synaptic activity and substrate consumption surge over the first few years of life Johnston, 1995 Johnston, , 2003 Nishino et al., 1997; Erecinska et al., 2004; Wintermark et al., 2004) . These changes are accompanied by a 3-fold increase of arterial surface area (Fig. 3) , a 50-100% increase of MCA blood velocity (Fig. 4) , and a 5-fold increase of CBF (Fig. 7) . If GCDH deficiency interferes with brain metabolism Strauss et al., 2007; Zinnanti et al., 2007) and flow-metabolism coupling remains intact, metabolic impairment should be reflected by lower CBF and velocity. This is in fact the case; asymptomatic patients between 6 months and 5 years of age had MCA mean velocities 18-26% below control values (Fig. 4) , similar to the 14-28% decrease of glucose tracer uptake measured by positron emission tomography (Strauss et al., 2007) . In large feeding vessels (Fig. 3) , slow velocity was offset by increased vessel calibre according to the equation: Flow = (mean velocity)(cross-sectional area). This relationship suggests that an 18%-26% decrease in velocity through an artery with 34%-42% more cross-sectional area would maintain flow near or above normal levels. In capillaries, however, transit time has the predominant effect on flow (Fig. 6) (Hudetz, 1997a) . Thus, three patients who had elevated CBV nevertheless had low tissue blood flow due to slow transit (Table 1) . These changes appear to affect all grey matter, not just the striatum (Figs 9  and 10 ). We cannot explain the discrepancy between estimated Figure 8 Representative T 2 and corresponding perfusion CT images from GA1 patients in three clinical groups: chronic brain injury (atrophic phase, left column), non-injured (middle column) and acute cytotoxic phase of striatal necrosis (right column). MTT = mean transit time. Figure 9 Upper panels show perfusion CT measurements from four children with GA1 (white symbols) compared with nine grey matter regions from age-matched control subjects (grey squares). Perfusion data are plotted as mean transit time (MTT) (seconds) and CBV (ml/100g) against CBF (ml/100 g min). Lower panels depict serial MCA velocity profiles evaluated by serial transcranial colour Doppler ultrasound measurements from these same patients; black arrows indicate timing of perfusion scans. From left to right: (A) two 20-month-old children, one non-injured (white circles) and one injured (white triangles), had prolonged mean transit time (slow velocity), high CBV and low CBF throughout grey matter. The mean transit time/CBF and CBV/CBF ratios were elevated, indicating low perfusion pressure and diminished autoregulatory reserve. (B) Ten hours into acute striatal crisis (white diamonds), an 8-month-old boy had low CBV and short mean transit time (high velocity) with heterogenous striatal CBF values (see Fig. 2 ). At 100 h (white triangles), CBV remained low and mean transit time had normalized, resulting in more uniform ischaemia throughout deep grey matter. (C) In a 5.5-month-old child with chronic striatal lesions, mean transit time and CBV were low, CBF was normal, and regional perfusion was homogenous. flow in the MCA (i.e. mean velocity Â cross-sectional area) and measured flow on perfusion scans; these data indicate that an unmeasured fraction of blood may enter the skull and bypass tissue capillaries.
Low CBF and elevated mean transit time are characteristic of many pathological conditions (Ferrari et al., 1992; Bauer et al., 1999; Bristow et al., 2005; Wintermark et al., 2005; Czosnyka et al., 2009 ), but to our knowledge this is the first report of chronic haemodynamic changes associated with an organic acid disorder. To understand the meaning of these changes better, it is instructive to consider how GCDH deficiency affects brain metabolism. Evidence supports the following model.
(i) Cerebral production of glutaryl-CoA and derivative organic acids: lysine, in competition with arginine and ornithine, crosses the blood-brain barrier via facilitative cationic amino acid transporters encoded by the genes SLC7A1 and SLC7A2 (http://biogps.gnf.org) (Smith and Stoll, 1998; Strauss, 2005; Closs et al., 2006; O'Kane et al., 2006; Zinnanti et al., 2007) . A small proportion of intracerebral lysine (and tryptophan) constitutively enters the mitochondrial degradation pathway. Glutaryl-CoA, a 5-carbon ester, accumulates proximal to the GCDH block and is a poor substrate for mitochondrial glycine-and acylcarnitinetransferases (Ramsay et al., 2001; Sherman et al., 2008) . Based on the biochemical distinction between GA1 and glutaric aciduria type 3, the formation of non-degraded glutaryl-CoA appears essential to biochemical toxicity (Sherman et al., 2008) . (ii) Toxin entrapment: because glutaryl-CoA and its derivatives (particularly glutarate) do not readily cross the blood-brain barrier (Hassel et al., 2002; Ferreira Gda et al., 2005; Sauer et al., 2006; Keyser et al., 2008) , they accumulate to high concentrations within the brain (Funk et al., 2005; Sauer et al., 2006; Zinnanti et al., 2006) , where they may inhibit substrate consumption by 15%-30% (Strauss et al., 2007) . (iii) Threshold energy failure: striatal tissue appears to function adequately in this compromised state provided ATP hydrolysis does not decrease below a minimum threshold ($50%-60% of the normal metabolic rate) necessary to maintain membrane electrical gradients (Erecinska and Silver, 1994; Riepe et al., 1995; Brouillet et al., 1998; Hoshi et al., 2005) . However, vulnerable medium spiny neurons can undergo necrotic cell death if this threshold is breeched as a result of further metabolic or haemodynamic derangements (Nishino et al., 1997; Brouillet et al., 1998; Calabresi et al., 2000; Nishino et al., 2000) (iv) Developmental vulnerability: 'normal' metabolic rate is a dynamic concept; metabolic requirements vary across the brain and change throughout development Erecinska et al., 2004) . In GA1, striatal necrosis always occurs during the brain's most robust developmental phase, as amino acids are being incorporated into cerebral protein and energy requirements are increasing Strauss, 2005 Strauss, , 2007 . During the first few years of life, higher blood-to-brain lysine transport supports brain protein accretion (Banos, 1978) but also entails potential for more flux through the degradation pathway (Strauss, 2005) . Thus, the brain may have its highest content of glutaryl-CoA, glutarate and 3-hydroxyglutarate when it is energetically and haemodynamically most vulnerable (Figs 4 and 6) (Erecinska et al., 2004; Funk et al., 2005; Strauss, 2005) .
Because reductions of MCA velocity (Fig. 4) and glucose tracer uptake are comparable (Strauss et al., 2007) , we believe that coupling between blood flow and energy metabolism is intact; i.e. that biochemical toxicity entrains the haemodynamic changes. If so, then low velocity (high mean transit time) might compensate for impaired glucose utilization by increasing the time for glucose extraction (Gjedde et al., 1990) .
Perfusion pressure and 'metabolic' stroke
We cannot exclude the possibility that haemodynamics play a primary role in 'metabolic' stroke, especially when considering the relationship between flow and velocity. Flow through a blood vessel can be expressed in two different ways, as the product of cross-sectional area and velocity (Q = pr 2 v) or by the Hagen-Pouseille equation (Q = pPr 4 /8ln) (Despopoulos and Silbernagl, 2003) , where Q is flow, r is vessel radius, l is vessel length, n is blood viscosity and P is perfusion pressure, the difference between arterial blood pressure and cerebral venous pressure (Auer and Sutherland, 2002) . Combining these equations reveals the relationship between velocity and perfusion pressure:
Assuming relatively constant path length (l) and viscosity (n) under our study conditions, as well as preservation or increase of vessel radius (r; Fig. 3 ), low MCA velocity in non-injured children is likely to reflect decreased cerebral perfusion pressure (Fig. 4) . Two additional observations support this. First, pulsatility tended to be elevated in non-injured patients after 7 months of age (Fig. 5) , and studies have shown that MCA pulsatility is inversely related to perfusion pressure (Bellner et al., 2004) . Second, CBV and mean transit time were high relative to CBF in some children (Figs 9A and 10A ). This pattern (elevated mean transit time/CBF and CBV/CBF ratios) typically indicates arteriolar dilation, increased CBV and low perfusion pressure (Gibbs et al., 1984; Lewis et al., 2001) ; it raises the important question of autoregulatory reserve in GA1.
As perfusion pressure changes, cerebral autoregulation maintains constant CBF by altering the tone of arterioles (Fig. 12 ) (Wahl and Schilling, 1993; Lewis et al., 2001; Czosnyka et al., 2009; Schmidt et al., 2009) . Maximum arteriolar dilation defines the limit of autoregulation beyond which further reductions of perfusion pressure-due either to reduced systemic blood pressure or increased tissue pressure-reduce CBF Czosnyka et al., 2009; Schmidt et al., 2009; Zweifel et al., 2009) . Our results suggest that some non-injured patients may live at the brink of this autoregulatory limit (Figs. 4, 5 , 7, 9A and 10A), placing them at risk for ischaemic brain injury (Ferrari et al., 1992; Derdeyn et al., 2002) .
Haemodynamics, hydrodynamics and haemorrhage
Reduced perfusion pressure can result from systemic hypotension, arteriolar dilation, increased tissue and cerebral venous pressure, or some combination of these (Fig. 12) . We did not systematically measure blood pressure in study subjects and although cerebrospinal fluid pressure was high in one neonate (Case 1, Fig. 1 ), this observation is insufficient to generalize. There are, however, some clues as to the mechanism of reduced perfusion pressure in GA1. Most children with GA1 have a dilated vein of Galen (Strauss et al., 2007) and some suffer intradural and retinal haemorrhages (Martinez-Lage, 1996; Morris et al., 1999) . Young lysine-fed Gcdh À/-mice develop cerebral venous congestion and haemorrhages in parallel with striatal lesions (Zinnanti et al., 2006) . Non-injured patients have high CBV (Table 1 , Fig. 9A ), about 80% of which is venous (Powers, 1994) . Together, these observations suggest that cerebral venous volume and pressure are elevated in both mice and humans with GCDH deficiency (Fig. 12) . In the brain, elevated venous pressure impedes resorption of interstitial fluid (Johanson et al., 2008) , which communicates with CSF through gaps in the glia limitans (Fig. 12) . This increases both interstitial and CSF fluid volume (Reulen et al., 1977; Rosenberg et al., 1982; Makkat 2003) . In GA1 patients of all ages, regardless of injury status, T 2 hyperintensity and high water diffusion in periventricular white matter around the frontal and occipital horns (Fig. 11) , medial lemniscus, pallidum and dentate nucleus might indicate interstitial (i.e. vasogenic) oedema (Reulen et al., 1977; Strauss et al., , 2007 Twomey et al., 2003; Harting et al., 2009) . These regions may simply function as conduits for bulk transport of interstitial fluid from brain to CSF (Fig. 12) (Pasquini et al., 1977; Rosenberg et al., 1982; Takei et al., 1987; Hunt et al., 2003) . This could explain why most GA1 patients who have abnormal subcortical and brainstem white matter signals do not have clinical signs of white matter disease Twomey et al., 2003; Harting et al., 2009) .
Increased cerebral venous volume and its relationship to the interstitial fluid compartment (Fig. 12) can tie together several puzzling phenomena in GA1, including increased CSF expansion in neonates (Fig. 1) (Mandel et al., 1991; Martinez-Lage, 1996; Hernandez-Palazon et al., 2006) , intradural fluid and blood collections (Martinez-Lage, 1996; Twomey et al., 2003) , retinal bleeding (Knapp et al., 2002; Gago et al., 2003) , dilation of the deep cerebral veins (Zinnanti et al., 2006; Strauss et al., 2007) , white matter vacuolization (Soffer et al., 1992; Zinnanti et al., 2006; Harting et al., 2009) and increased brain weight (Strauss, 2005) . Along these lines, it is interesting to note that the presenting complaint of an adult-onset GA1 patientheadache (Bahr et al., 2002) -is more suggestive of venous congestion or idiopathic intracranial hypertension than leukodystrophy (Dahlerup et al., 1985; Tisell et al., 2003; Owler et al., 2005; Mullen et al., 2008; Pujari et al., 2008) .
What happens to blood flow during a striatal crisis?
During the acute phase of striatal degeneration, there was a fundamental change in the character of blood flow ( et al., 2007) . Individuals with GA1 have elevated water diffusion in the caudate, anterior putamen and posterior-lateral putamen that corresponds to neuronal loss and reactive gliosis (arrows). However, water diffusion tends to be increased throughout the brain, particularly in deep white matter of the centrum semiovale (arrowheads). In older GA1 patients, these deep white matter areas typically show mild symmetrically increased T 2 and fluid attenuated inversion recovery signal intensity. Elevated extrastriatal diffusion values may reflect a generalized expansion of the interstitial space within the brain, most prominent within deep white matter. CSfr = centrum semiovale-frontal; CSoc = centrum semiovale-occipital; MT = large myelin tracks (average of middle cerebellar peduncle = genu and splenium of corpus callosum); Pons = dorsal pontine reticular formation; SN = substantia nigra; Th = thalamus; Cd = caudate; Put = anterior putamen; PLPut = posterior-lateral putamen; GP = globus pallidus; CGM = average of cortical, parietal, and occipital grey matter. Asterisks denote regions where GA1 and control values differ (P50.005).
Figure 12
Left panel: under normal conditions, approximately half of the ATP energy generated by mitochondria is used to operate NaK-ATPase and maintain transmembrane electrochemical gradients. The blood flow that delivers glucose and oxygen to tissue is determined by the perfusion pressure-arterial blood pressure (BPa) minus venous (intracranial) pressure-and the resistance of arterioles (Ra). Two parallel capillary populations, exchange vessels (MTTex) and non-exchanging thoroughfare channels (MTTth), may carry blood through tissue. In the normal state, exchange vessels-which are under autoregulatory control and have higher mean transit time (MTT)-carry the majority of flow. Although thoroughfare channels probably originate after resistance arterioles, they are drawn pre-arteriolar in the figure to emphasize that they do not exhibit normal autoregulation in vivo (see Hudetz 1997a, b) . The cerebral veins constitute about 80% of CBV and are influenced by interstitial fluid pressure and dural sinus pressure (Ps). Volume and pressure within the venous system affect the net production of interstitial fluid (Visf). This fluid surrounds nerves and glia and communicates with cerebrospinal fluid (Vcsf) through gaps in the glia limitans. Middle panel: the premorbid state is characterized by higher blood volume and slower transit. We propose that a primary metabolic disturbance reduces ATP production rate, which entrains arteriolar dilation (reduced Ra) and proportionally higher flow through exchange capillaries. These changes maximize the time for substrate extraction at any given flow rate, but result in higher venous volume and pressure; the latter can increase net production of interstitial fluid and constitutes a risk for intradural and retinal haemorrhages. Right panel: further metabolic (e.g. fever) or haemodynamic (e.g. hypotension) challenges can reduce ATP production below a critical threshold, causing refractory depolarization and cytotoxic swelling. Under these conditions, heterogeneous flow and fast transit may reflect redistribution of blood to thoroughfare channels.
and 9B) which might reflect regional perfusion pressure gradients (Reulen et al., 1977; Vollmar et al., 1999) or capillary redistribution. Hudetz (1997a, b) hypothesized that non-exchanging 'thoroughfare channels' with high velocity and no autoregulation run in parallel with true functional capillaries in the brain (Fig. 12) . Thoroughfare channels carry a smaller fraction of total flow so that perfusion characteristics in vivo are more indicative of functional (i.e. autoregulating) capillaries. Because both exchange and thoroughfare channels contribute to measured perfusion, a shift in relationships among CBV, mean transit time and CBF (e.g. Figs 9B and 10B ) may signify a shift in the distribution of flow between them. In non-injured children, blood might flow preferentially through exchange capillaries to optimize 'functional' capillary density and glucose extraction time (Gjedde et al., 1990) . If metabolic activity of striatal neurons declines suddenly, flow may redistribute to non-exchanging vessels (Fig. 9B) (Hudetz, 1997a) . Transcranial Doppler data support this idea. Brain-injured children had relative increases of MCA velocity between 6 and 18 months and reduced velocity thereafter (Fig. 4) . This surge appears after the brain is injured (Fig. 9B and C) and may depict transient uncoupling of flow and metabolism in damaged tissue. A similar phenomenon occurs immediately after an occlusive stroke; upon reperfusion, nutrient and oxygen flow to necrotic tissue greatly exceed metabolic demand (Gjedde et al., 1990) .
Clinical implications of haemodynamic changes in glutaric aciduria type 1
We are now in a position to imagine a chain of events that culminates in striatal degeneration: (i) glutaryl-CoA and its derivatives, glutarate and 3-hydroxyglutarate, are constitutively produced by, and accumulate within, GCDH-deficient brain cells (Strauss, 2005; Sauer et al., 2006; Zinnanti et al., 2007) ; (ii) entrapped metabolites interfere with cerebral energy metabolism, detected as a 25%-30% reduction of striatal fluorodeoxyglucose uptake (Strauss et al., 2007) ; (iii) metabolic toxicity entrains haemodynamic changes that decrease capillary blood velocity (increase substrate transit time), increase CBV and maintain flow-metabolism coupling; (iv) MCA perfusion pressure is reduced, most likely as a result of arteriolar dilation, resulting in venous congestion and elevated interstitial fluid pressure (Fig. 12) ; and (v) physiologic conditions which increase energy requirements (e.g. fever) (Laptook and Corbett, 2002) , decrease energy supply (e.g. hypoglycaemia), threaten perfusion (e.g. dehydration, hypotension, intracranial hypertension), or produce these problems in combination, could decrease striatal energy turnover below a critical threshold and lead to necrosis. Such a model suggests that 'metabolic stroke' arises from a complex interplay of metabolic and haemodynamic phenomena, as has been proposed for other histotoxins such as 3-nitropropionic acid, cyanide and carbon monoxide (Chyi and Chang, 1999; Auer and Sutherland, 2002) .
Our model assumes that metabolic toxicity is the primary cause of developmental brain injury and secondary haemodynamic changes amplify the risk. This means that intravenous infusions during illnesses, prescribed to provide 10-12 mg/kg min of dextrose and about 150% the maintenance fluid requirement, might have two important therapeutic actions: to increase dextrose delivery to the brain and to increase cerebral perfusion pressure. These data also explain age-related susceptibility; the risk for brain injury subsides following the brain's natural plateau of energy expenditure, protein accretion and blood flow (Figs 4  and 7) .
This study opens up new areas for clinical investigation. Measurement of MCA velocity and cerebral perfusion in a culturally and genetically broader group will reveal if cerebrovascular patterns are related to genotype or biochemical phenotype. Such validation is essential before our findings can be generalized to the larger GA1 population. Longitudinal studies could more closely analyse the relationship between MCA velocity and neurological risk, similar to the strategy used for sickle cell anaemia (Adams, 2007) . However, our preliminary findings suggest that Doppler data may be an imperfect tool for this purpose because of marked intra-individual variation over time (Fig. 9 , lower panels) and considerable overlap between injured and non-injured patients.
Future haemodynamic studies should include measurement of arterial blood pressure and might also examine velocity in deep cerebral veins (Valdueza et al., 1996; Doepp et al., 2006) . Given the haemodynamic similarities of GA1 to idiopathic intracranial hypertension (Owler et al., 2005) and high-altitude encephalopathy (Wilson et al., 2009 ), a more systematic study of retinal pathology in GA1 may be warranted and, when indicated, lumbar puncture should always prompt measurement of opening pressure.
Perfusion CT is a powerful method for interrogating haemodynamics, but it is logistically difficult in children and involves small, but measurable, radiation exposure (Wintermark et al., 2001 (Wintermark et al., , 2004 . Advances in magnetic resonance imaging (Olivot et al., 2009; Zaharchuk et al., 2009) should increase the number of perfusion studies that can be done safely in children. More extensive perfusion imaging in a variety of clinical settings will be necessary to determine how specific treatment variables (e.g. lysine-restricted diet, L-carnitine etc.) affect brain physiology. If blood flow changes are indeed linked to the biochemical status of striatal neurons, interventions that decrease cerebral production of glutaryl-CoA should improve cerebral energetics and produce measurable increases in MCA velocity and brain perfusion.
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